Secukinumab in psoriasis: A single-center experience

Agaoglu E., KAYA ERDOĞAN H., ACER E., SARAÇOĞLU Z. N., BİLGİN M.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, vol.55, no.3, pp.125-129, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 55 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.4274/turkderm.galenos.2021.75046
  • Journal Name: TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.125-129
  • Keywords: Secukinumab, psoriasis, biologic treatment, efficacy, safety, SEVERE PLAQUE PSORIASIS, CLINICAL-EFFICACY, BODY-WEIGHT, SAFETY, MODERATE, MULTICENTER
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background and Design: Several randomized clinical trials demonstrated the safety and efficacy of secukinumab in the systemic treatment of moderate-w , ere psoriasis; however, real-life data is limited. Thus, this study aimed to assess the efficacy and safety of secukinumab in patients with psoriasis.